Skip to content
healthcare.dev

Raloxifene Hydrochloride

NDC 50268-694, Raloxifene Hydrochloride, tablet, film coated, from AvPAK.

Product NDC
50268-694
Status
Listed
Labeler
AvPAK
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208206
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-694 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RALOXIFENE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
50268-694-155026806941550 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-694-15) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-694-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6f7eb934-aa60-51e1-e053-2a91aa0a3914
  • NADAC price for package 50268069415

    GET /v1/drugs/nadac/50268069415

Use it

Look up 50268-694 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-694 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-694. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.